The Antiviral Drugs Market is estimated to grow at a CAGR of 6.3% during the period 2022-2035, claims Roots Analysis
Over the years, there has been a growing focus on the development of safe and effective novel antiviral therapeutics owing to the rising cases of life-threatening viral diseases
Roots Analysis is pleased to announce the publication of its recent study, titled, “Antiviral Drugs Market, 2022 – 2035”
To get a sample copy of the latest market report, visit
The study features an in-depth analysis, highlighting the capabilities of antiviral drug developers engaged in this domain. Amongst other elements, the report features:
A detailed assessment of the current market landscape of commercially available antiviral drugs.
A detailed assessment of the current market landscape of clinical-stage antiviral drugs.
An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2019-2022 (till May).
A detailed analysis of investments that have been made into companies engaged in the antiviral drugs domain, during the period 2019-2022 (till May).
A qualitative analysis of the five competitive forces under an insightful Porter’s Five Forces framework.
Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in development of antiviral drugs.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
Mechanism of Action
Reverse Transcriptase Inhibitors
Human Immunodeficiency Virus Infection
Herpes Simplex Virus Infection
Other Target Indications
Type of Drug Target
Type of Therapy
Key Geographical Regions
Rest of the World
Key companies covered in the report
Johnson & Johnson
For additional details, please visit https://www.rootsanalysis.com/reports/antiviral-drugs-market.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
+1 (415) 800 3415